Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
2 NC counties are under alert, including Johnston County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nkarta Inc
(NQ:
NKTX
)
5.320
+0.170 (+3.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nkarta Inc
< Previous
1
2
3
4
5
Next >
Why Nkarta Stock Is Soaring Today
August 14, 2024
One analyst is now more bullish about this clinical-stage biotech stock.
Via
The Motley Fool
UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
August 14, 2024
Via
Benzinga
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
August 14, 2024
Via
Benzinga
NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024
August 13, 2024
NKTX stock results show that Nkarta beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
NKTX Stock Earnings: Nkarta Beats EPS for Q1 2024
May 09, 2024
NKTX stock results show that Nkarta beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 13, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 13, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President
July 16, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
3 Undervalued Stocks Primed for a 2X Return
July 01, 2024
Discover compelling investment opportunities with top undervalued stocks for high returns leading in healthcare and software.
Via
InvestorPlace
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
June 27, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
May 09, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
Opportunity Alert: 3 Undiscovered Stocks About to Explode on Wall Street’s Radar
May 07, 2024
Explore these undiscovered stock picks attached with rapid growth in biotechnology, oil and gas, and pharmaceuticals.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 12, 2024
Via
Benzinga
Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing
April 11, 2024
Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D...
Via
Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
April 08, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
April 05, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
April 05, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Nasdaq Turns Higher; Akanda Shares Plunge
March 25, 2024
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 25, 2024
Via
Benzinga
Crude Oil Moves Higher; US New Home Sales Fall In February
March 25, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 25, 2024
We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning.
Via
InvestorPlace
Nkarta Announces Pricing of $240 Million Underwritten Offering
March 25, 2024
From
Nkarta, Inc.
Via
GlobeNewswire
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 22, 2024
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.
Via
Benzinga
Stocks Level Off, S&P 500 Nears Best Week Of 2024, NVIDIA Rallies For 11th Week, Bitcoin Sinks: What's Driving Markets Friday?
March 22, 2024
Stocks slightly retreated during New York’s morning session on Friday, following another robust week of gains fueled by a dovish Federal Reserve meeting, which underscored Chair Jerome Powell‘s...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Is Cancer Drug-Developer Nkarta Stock Trading Lower On Friday?
March 22, 2024
Nkarta closed patient enrollment in NKX101 clinical trial, reallocating focus to lead program NKX019 for autoimmune disease. Recent expansion into autoimmune disease with FDA clearance for NKX019 in...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
March 22, 2024
Via
Benzinga
Why Top 1% Biotech Stock Nkarta Just Plummeted, Undercutting Its 50-Day Line
March 22, 2024
The company is deprioritizing a key piece of its pipeline in favor of a potential lupus treatment.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 22, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.